APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pruritus Drugs

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Pruritus Drugs Market Analysis and Forecast 2026-2032

22 December 2025197 pages

Choose your research edition.

Industry ResearchPruritus Drugs Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Pruritus Drugs Industry Growth and Trends Forecast to 203285 pages · $3,450 USDMarket StructureGlobal Pruritus Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pruritus Drugs Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Pruritus Drugs Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Pruritus Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Pruritus Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Pruritus Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Pruritus Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Pruritus Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Pruritus Drugs include Sanofi, Pfizer Inc., GlaxoSmithKline Plc, Astellas Pharma Inc. and Allergan Plc, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Pruritus Drugs, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Pruritus Drugs, also provides the revenue of main regions and countries. Of the upcoming market potential for Pruritus Drugs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Pruritus Drugs revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Pruritus Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Pruritus Drugs revenue, projected growth trends, production technology, application and end-user industry.

Pruritus Drugs Segment by Company

Sanofi

Pfizer Inc.

GlaxoSmithKline Plc

Astellas Pharma Inc.

Allergan Plc

Pruritus Drugs Segment by Type

Parenteral

Oral

Topical

Pruritus Drugs Segment by Application

Oncological Pruritus

Hematologic Pruritus

Renal Pruritus

Endocrine Pruritus

Cholestatic Pruritus

Pruritus Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pruritus Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pruritus Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pruritus Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Pruritus Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Pruritus Drugs company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pruritus Drugs revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Pruritus Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Parenteral Major Player Table 3. Oral Major Player Table 4. Topical Major Player Table 5. Global Pruritus Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Oncological Pruritus Major Player Table 7. Hematologic Pruritus Major Player Table 8. Renal Pruritus Major Player Table 9. Endocrine Pruritus Major Player Table 10. Cholestatic Pruritus Major Player Table 11. Pruritus Drugs Industry Trends Table 12. Pruritus Drugs Industry Drivers Table 13. Pruritus Drugs Industry Opportunities and Challenges Table 14. Pruritus Drugs Industry Restraints Table 15. Global Pruritus Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 16. Global Pruritus Drugs Market Size by Region (2021-2026) & (US$ Million) Table 17. Global Pruritus Drugs Market Share by Region (2021-2026) Table 18. Global Pruritus Drugs Market Size by Region (2027-2032) & (US$ Million) Table 19. Global Pruritus Drugs Market Share by Region (2027-2032) Table 20. Global Pruritus Drugs Revenue by Players (US$ Million) & (2021-2026) Table 21. Global Pruritus Drugs Revenue Market Share by Players (2021-2026) Table 22. Global Pruritus Drugs Key Players Ranking, 2024 VS 2025 VS 2026 Table 23. Global Pruritus Drugs Key Players Headquarters & Area Served Table 24. Global Pruritus Drugs Players, Product Type & Application Table 25. Global Pruritus Drugs Players Establishment Date Table 26. Global Players Market Concentration Ratio (CR5 and HHI) Table 27. Global Pruritus Drugs by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 28. Global Pruritus Drugs Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Pruritus Drugs Revenue by Type (2021-2026) & (US$ Million) Table 30. Global Pruritus Drugs Revenue by Type (2027-2032) & (US$ Million) Table 31. Global Pruritus Drugs Revenue Market Share by Type (2021-2026) Table 32. Global Pruritus Drugs Revenue Market Share by Type (2027-2032) Table 33. Global Pruritus Drugs Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Pruritus Drugs Revenue by Application (2021-2026) & (US$ Million) Table 35. Global Pruritus Drugs Revenue by Application (2027-2032) & (US$ Million) Table 36. Global Pruritus Drugs Revenue Market Share by Application (2021-2026) Table 37. Global Pruritus Drugs Revenue Market Share by Application (2027-2032) Table 38. Sanofi Company Information Table 39. Sanofi Business Overview Table 40. Sanofi Pruritus Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 41. Sanofi Pruritus Drugs Product Portfolio Table 42. Sanofi Recent Development Table 43. Pfizer Inc. Company Information Table 44. Pfizer Inc. Business Overview Table 45. Pfizer Inc. Pruritus Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 46. Pfizer Inc. Pruritus Drugs Product Portfolio Table 47. Pfizer Inc. Recent Development Table 48. GlaxoSmithKline Plc Company Information Table 49. GlaxoSmithKline Plc Business Overview Table 50. GlaxoSmithKline Plc Pruritus Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 51. GlaxoSmithKline Plc Pruritus Drugs Product Portfolio Table 52. GlaxoSmithKline Plc Recent Development Table 53. Astellas Pharma Inc. Company Information Table 54. Astellas Pharma Inc. Business Overview Table 55. Astellas Pharma Inc. Pruritus Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 56. Astellas Pharma Inc. Pruritus Drugs Product Portfolio Table 57. Astellas Pharma Inc. Recent Development Table 58. Allergan Plc Company Information Table 59. Allergan Plc Business Overview Table 60. Allergan Plc Pruritus Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 61. Allergan Plc Pruritus Drugs Product Portfolio Table 62. Allergan Plc Recent Development Table 63. North America Pruritus Drugs Revenue by Type (2021-2026) & (US$ Million) Table 64. North America Pruritus Drugs Revenue by Type (2027-2032) & (US$ Million) Table 65. North America Pruritus Drugs Revenue by Application (2021-2026) & (US$ Million) Table 66. North America Pruritus Drugs Revenue by Application (2027-2032) & (US$ Million) Table 67. North America Pruritus Drugs Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 68. North America Pruritus Drugs Revenue by Country (2021-2026) & (US$ Million) Table 69. North America Pruritus Drugs Revenue by Country (US$ Million) & (2027-2032) Table 70. Europe Pruritus Drugs Revenue by Type (2021-2026) & (US$ Million) Table 71. Europe Pruritus Drugs Revenue by Type (2027-2032) & (US$ Million) Table 72. Europe Pruritus Drugs Revenue by Application (2021-2026) & (US$ Million) Table 73. Europe Pruritus Drugs Revenue by Application (2027-2032) & (US$ Million) Table 74. Europe Pruritus Drugs Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 75. Europe Pruritus Drugs Revenue by Country (2021-2026) & (US$ Million) Table 76. Europe Pruritus Drugs Revenue by Country (US$ Million) & (2027-2032) Table 77. China Pruritus Drugs Revenue by Type (2021-2026) & (US$ Million) Table 78. China Pruritus Drugs Revenue by Type (2027-2032) & (US$ Million) Table 79. China Pruritus Drugs Revenue by Application (2021-2026) & (US$ Million) Table 80. China Pruritus Drugs Revenue by Application (2027-2032) & (US$ Million) Table 81. Asia Pruritus Drugs Revenue by Type (2021-2026) & (US$ Million) Table 82. Asia Pruritus Drugs Revenue by Type (2027-2032) & (US$ Million) Table 83. Asia Pruritus Drugs Revenue by Application (2021-2026) & (US$ Million) Table 84. Asia Pruritus Drugs Revenue by Application (2027-2032) & (US$ Million) Table 85. Asia Pruritus Drugs Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 86. Asia Pruritus Drugs Revenue by Region (US$ Million) & (2021-2026) Table 87. Asia Pruritus Drugs Revenue by Region (US$ Million) & (2027-2032) Table 88. SAMEA Pruritus Drugs Revenue by Type (2021-2026) & (US$ Million) Table 89. SAMEA Pruritus Drugs Revenue by Type (2027-2032) & (US$ Million) Table 90. SAMEA Pruritus Drugs Revenue by Application (2021-2026) & (US$ Million) Table 91. SAMEA Pruritus Drugs Revenue by Application (2027-2032) & (US$ Million) Table 92. SAMEA Pruritus Drugs Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 93. SAMEA Pruritus Drugs Revenue by Country (2021-2026) & (US$ Million) Table 94. SAMEA Pruritus Drugs Revenue by Country (US$ Million) & (2027-2032) Table 95. Research Programs/Design for This Report Table 96. Authors List of This Report Table 97. Secondary Sources Table 98. Primary Sources List of Figures Figure 1. Pruritus Drugs Image Figure 2. Global Pruritus Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pruritus Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 4. Parenteral Image Figure 5. Oral Image Figure 6. Topical Image Figure 7. Global Pruritus Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Pruritus Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 9. Oncological Pruritus Image Figure 10. Hematologic Pruritus Image Figure 11. Renal Pruritus Image Figure 12. Endocrine Pruritus Image Figure 13. Cholestatic Pruritus Image Figure 14. Global Pruritus Drugs Market Size (US$ Million) & (2021-2032) Figure 15. Global Pruritus Drugs Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Pruritus Drugs Market Share by Region: 2021 VS 2025 VS 2032 Figure 17. Global Pruritus Drugs Players Revenue Share Top 10 and Top 5 in 2025 Figure 18. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Pruritus Drugs Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Pruritus Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 21. Global Pruritus Drugs Revenue Market Share by Type (2021-2032) Figure 22. Global Pruritus Drugs Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Pruritus Drugs Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 24. Global Pruritus Drugs Revenue Market Share by Application (2021-2032) Figure 25. North America Pruritus Drugs Revenue YoY Growth (2021-2032) & (US$ Million) Figure 26. North America Pruritus Drugs Revenue Share by Type (2021-2032) Figure 27. North America Pruritus Drugs Revenue Share by Application (2021-2032) Figure 28. North America Pruritus Drugs Revenue Share by Country (2021-2032) Figure 29. United States Pruritus Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Canada Pruritus Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Mexico Pruritus Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Europe Pruritus Drugs Revenue YoY Growth (2021-2032) & (US$ Million) Figure 33. Europe Pruritus Drugs Revenue Share by Type (2021-2032) Figure 34. Europe Pruritus Drugs Revenue Share by Application (2021-2032) Figure 35. Europe Pruritus Drugs Revenue Share by Country (2021-2032) Figure 36. Germany Pruritus Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. France Pruritus Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. U.K. Pruritus Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Italy Pruritus Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Spain Pruritus Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Russia Pruritus Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Netherlands Pruritus Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Nordic Countries Pruritus Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. China Pruritus Drugs Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. China Pruritus Drugs Revenue Share by Type (2021-2032) Figure 46. China Pruritus Drugs Revenue Share by Application (2021-2032) Figure 47. Asia Pruritus Drugs Revenue YoY Growth (2021-2032) & (US$ Million) Figure 48. Asia Pruritus Drugs Revenue Share by Type (2021-2032) Figure 49. Asia Pruritus Drugs Revenue Share by Application (2021-2032) Figure 50. Asia Pruritus Drugs Revenue Share by Region (2021-2032) Figure 51. Japan Pruritus Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. South Korea Pruritus Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. India Pruritus Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Australia Pruritus Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Taiwan Pruritus Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Southeast Asia Pruritus Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. SAMEA Pruritus Drugs Revenue YoY Growth (2021-2032) & (US$ Million) Figure 58. SAMEA Pruritus Drugs Revenue Share by Type (2021-2032) Figure 59. SAMEA Pruritus Drugs Revenue Share by Application (2021-2032) Figure 60. SAMEA Pruritus Drugs Revenue Share by Country (2021-2032) Figure 61. Brazil Pruritus Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Argentina Pruritus Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Chile Pruritus Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Colombia Pruritus Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Peru Pruritus Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Saudi Arabia Pruritus Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Israel Pruritus Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. UAE Pruritus Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Turkey Pruritus Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Iran Pruritus Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Egypt Pruritus Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Parenteral
  • Oral
  • Topical
Applications
  • Oncological Pruritus
  • Hematologic Pruritus
  • Renal Pruritus
  • Endocrine Pruritus
  • Cholestatic Pruritus
Companies covered
  • Sanofi
  • Pfizer Inc.
  • GlaxoSmithKline Plc
  • Astellas Pharma Inc.
  • Allergan Plc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Pruritus Drugs Market by Type
  3. 1.2.1 Global Pruritus Drugs Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Parenteral
  5. 1.2.3 Oral
  6. 1.2.4 Topical
  7. 1.3 Pruritus Drugs Market by Application
  8. 1.3.1 Global Pruritus Drugs Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Oncological Pruritus
  10. 1.3.3 Hematologic Pruritus
  11. 1.3.4 Renal Pruritus
  12. 1.3.5 Endocrine Pruritus
  13. 1.3.6 Cholestatic Pruritus
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Pruritus Drugs Market Dynamics
  1. 2.1 Pruritus Drugs Industry Trends
  2. 2.2 Pruritus Drugs Industry Drivers
  3. 2.3 Pruritus Drugs Industry Opportunities and Challenges
  4. 2.4 Pruritus Drugs Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Pruritus Drugs Market Perspective (2021-2032)
  2. 3.2 Global Pruritus Drugs Growth Trends by Region
  3. 3.2.1 Global Pruritus Drugs Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Pruritus Drugs Market Size by Region (2021-2026)
  5. 3.2.3 Global Pruritus Drugs Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Pruritus Drugs Revenue by Players
  2. 4.1.1 Global Pruritus Drugs Revenue by Players (2021-2026)
  3. 4.1.2 Global Pruritus Drugs Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Pruritus Drugs Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Pruritus Drugs Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Pruritus Drugs Key Players Headquarters & Area Served
  7. 4.4 Global Pruritus Drugs Players, Product Type & Application
  8. 4.5 Global Pruritus Drugs Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Pruritus Drugs Market CR5 and HHI
  11. 4.6.3 2025 Pruritus Drugs Tier 1, Tier 2, and Tier 3
5 Pruritus Drugs Market Size by Type
  1. 5.1 Global Pruritus Drugs Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Pruritus Drugs Revenue by Type (2021-2032)
  3. 5.3 Global Pruritus Drugs Revenue Market Share by Type (2021-2032)
6 Pruritus Drugs Market Size by Application
  1. 6.1 Global Pruritus Drugs Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Pruritus Drugs Revenue by Application (2021-2032)
  3. 6.3 Global Pruritus Drugs Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Sanofi
  2. 7.1.1 Sanofi Company Information
  3. 7.1.2 Sanofi Business Overview
  4. 7.1.3 Sanofi Pruritus Drugs Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Sanofi Pruritus Drugs Product Portfolio
  6. 7.1.5 Sanofi Recent Developments
  7. 7.2 Pfizer Inc.
  8. 7.2.1 Pfizer Inc. Company Information
  9. 7.2.2 Pfizer Inc. Business Overview
  10. 7.2.3 Pfizer Inc. Pruritus Drugs Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Pfizer Inc. Pruritus Drugs Product Portfolio
  12. 7.2.5 Pfizer Inc. Recent Developments
  13. 7.3 GlaxoSmithKline Plc
  14. 7.3.1 GlaxoSmithKline Plc Company Information
  15. 7.3.2 GlaxoSmithKline Plc Business Overview
  16. 7.3.3 GlaxoSmithKline Plc Pruritus Drugs Revenue and Gross Margin (2021-2026)
  17. 7.3.4 GlaxoSmithKline Plc Pruritus Drugs Product Portfolio
  18. 7.3.5 GlaxoSmithKline Plc Recent Developments
  19. 7.4 Astellas Pharma Inc.
  20. 7.4.1 Astellas Pharma Inc. Company Information
  21. 7.4.2 Astellas Pharma Inc. Business Overview
  22. 7.4.3 Astellas Pharma Inc. Pruritus Drugs Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Astellas Pharma Inc. Pruritus Drugs Product Portfolio
  24. 7.4.5 Astellas Pharma Inc. Recent Developments
  25. 7.5 Allergan Plc
  26. 7.5.1 Allergan Plc Company Information
  27. 7.5.2 Allergan Plc Business Overview
  28. 7.5.3 Allergan Plc Pruritus Drugs Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Allergan Plc Pruritus Drugs Product Portfolio
  30. 7.5.5 Allergan Plc Recent Developments
8 North America
  1. 8.1 North America Pruritus Drugs Revenue (2021-2032)
  2. 8.2 North America Pruritus Drugs Revenue by Type (2021-2032)
  3. 8.2.1 North America Pruritus Drugs Revenue by Type (2021-2026)
  4. 8.2.2 North America Pruritus Drugs Revenue by Type (2027-2032)
  5. 8.3 North America Pruritus Drugs Revenue Share by Type (2021-2032)
  6. 8.4 North America Pruritus Drugs Revenue by Application (2021-2032)
  7. 8.4.1 North America Pruritus Drugs Revenue by Application (2021-2026)
  8. 8.4.2 North America Pruritus Drugs Revenue by Application (2027-2032)
  9. 8.5 North America Pruritus Drugs Revenue Share by Application (2021-2032)
  10. 8.6 North America Pruritus Drugs Revenue by Country
  11. 8.6.1 North America Pruritus Drugs Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Pruritus Drugs Revenue by Country (2021-2026)
  13. 8.6.3 North America Pruritus Drugs Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Pruritus Drugs Revenue (2021-2032)
  2. 9.2 Europe Pruritus Drugs Revenue by Type (2021-2032)
  3. 9.2.1 Europe Pruritus Drugs Revenue by Type (2021-2026)
  4. 9.2.2 Europe Pruritus Drugs Revenue by Type (2027-2032)
  5. 9.3 Europe Pruritus Drugs Revenue Share by Type (2021-2032)
  6. 9.4 Europe Pruritus Drugs Revenue by Application (2021-2032)
  7. 9.4.1 Europe Pruritus Drugs Revenue by Application (2021-2026)
  8. 9.4.2 Europe Pruritus Drugs Revenue by Application (2027-2032)
  9. 9.5 Europe Pruritus Drugs Revenue Share by Application (2021-2032)
  10. 9.6 Europe Pruritus Drugs Revenue by Country
  11. 9.6.1 Europe Pruritus Drugs Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Pruritus Drugs Revenue by Country (2021-2026)
  13. 9.6.3 Europe Pruritus Drugs Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Pruritus Drugs Revenue (2021-2032)
  2. 10.2 China Pruritus Drugs Revenue by Type (2021-2032)
  3. 10.2.1 China Pruritus Drugs Revenue by Type (2021-2026)
  4. 10.2.2 China Pruritus Drugs Revenue by Type (2027-2032)
  5. 10.3 China Pruritus Drugs Revenue Share by Type (2021-2032)
  6. 10.4 China Pruritus Drugs Revenue by Application (2021-2032)
  7. 10.4.1 China Pruritus Drugs Revenue by Application (2021-2026)
  8. 10.4.2 China Pruritus Drugs Revenue by Application (2027-2032)
  9. 10.5 China Pruritus Drugs Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Pruritus Drugs Revenue (2021-2032)
  2. 11.2 Asia Pruritus Drugs Revenue by Type (2021-2032)
  3. 11.2.1 Asia Pruritus Drugs Revenue by Type (2021-2026)
  4. 11.2.2 Asia Pruritus Drugs Revenue by Type (2027-2032)
  5. 11.3 Asia Pruritus Drugs Revenue Share by Type (2021-2032)
  6. 11.4 Asia Pruritus Drugs Revenue by Application (2021-2032)
  7. 11.4.1 Asia Pruritus Drugs Revenue by Application (2021-2026)
  8. 11.4.2 Asia Pruritus Drugs Revenue by Application (2027-2032)
  9. 11.5 Asia Pruritus Drugs Revenue Share by Application (2021-2032)
  10. 11.6 Asia Pruritus Drugs Revenue by Country
  11. 11.6.1 Asia Pruritus Drugs Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Pruritus Drugs Revenue by Country (2021-2026)
  13. 11.6.3 Asia Pruritus Drugs Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Pruritus Drugs Revenue (2021-2032)
  2. 12.2 SAMEA Pruritus Drugs Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Pruritus Drugs Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Pruritus Drugs Revenue by Type (2027-2032)
  5. 12.3 SAMEA Pruritus Drugs Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Pruritus Drugs Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Pruritus Drugs Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Pruritus Drugs Revenue by Application (2027-2032)
  9. 12.5 SAMEA Pruritus Drugs Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Pruritus Drugs Revenue by Country
  11. 12.6.1 SAMEA Pruritus Drugs Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Pruritus Drugs Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Pruritus Drugs Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst